Metraipolis › archive › dc_c2b64ff55d98

Real-World Treatment Patterns and Survival Outcomes in Metastatic Triple Negative Breast Cancer: Immunotherapy- Versus Anti-Angiogenic… — Europe PMC PMID:40956004

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40956004
DOI
10.1002/cam4.71164
License (as archived)
solo-consultazione
Archived
2026-11-10T04:29:59.941Z
SHA-256 of the archived text
982932661c56f845e41ba1757d9de2a651538613c457fbbfc50194fa39f68794
Stable URL of this page
https://metraipolis.com/documento/dc_c2b64ff55d98

How to cite

Real-World Treatment Patterns and Survival Outcomes in Metastatic Triple Negative Breast Cancer: Immunotherapy- Versus Anti-Angiogenic… — Europe PMC PMID:40956004 — Europe PMC (en), https://europepmc.org/article/MED/40956004 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2b64ff55d98 (Metraipolis archive dc_c2b64ff55d98, sha256 982932661c56f845e41ba1757d9de2a651538613c457fbbfc50194fa39f68794)
BibTeX
@misc{dcc2b64ff55d98,
  title = {Real-World Treatment Patterns and Survival Outcomes in Metastatic Triple Negative Breast Cancer: Immunotherapy- Versus Anti-Angiogenic… — Europe PMC PMID:40956004},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40956004},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2b64ff55d98; sha256 982932661c56f845e41ba1757d9de2a651538613c457fbbfc50194fa39f68794},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40956004. Agents can read the archived copy with the MCP tool read_document.